M R Arguedas

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. ncbi The critically ill liver patient: the variceal bleeder
    Miguel R Arguedas
    Division of Gastroenterology and Hepatology, UAB Liver Center, University of Alabama at Birmingham, UAB Liver Center, 1918 University Blvd, Birmingham, AL 35294, USA
    Semin Gastrointest Dis 14:34-8. 2003
  2. ncbi Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients
    M R Arguedas
    UAB Liver Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham, 35294 0007, USA
    Hepatology 34:28-31. 2001
  3. ncbi Screening for hepatocellular carcinoma: why, when, how?
    Miguel R Arguedas
    Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham, MCLM 281, 1918 University Boulevard, Birmingham, AL 35294, USA
    Curr Gastroenterol Rep 5:57-62. 2003
  4. ncbi Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis
    M R Arguedas
    Department of Medicine, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, AL 35294-0007, USA
    Aliment Pharmacol Ther 15:631-8. 2001
  5. ncbi Congenital vascular lesions of the gastrointestinal tract: blue rubber bleb nevus and Klippel-Trenaunay syndromes
    M R Arguedas
    Department of Medicine, University of Alabama at Birmingham, 35297-0007, USA
    South Med J 94:405-10. 2001
  6. ncbi Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis
    A W Dupont
    Division of Gastroenterology and Hepatology, Department of Medicine, University of Texas Medical Branch, Galveston, TX 77555 0764, USA
    Aliment Pharmacol Ther 26:431-41. 2007
  7. ncbi The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation
    M R Arguedas
    Department of Medicine, UAB Liver Center, University of Alabama at Birmingham, 35294-0007, USA
    Am J Gastroenterol 96:833-7. 2001
  8. ncbi Where do ERCP, endoscopic ultrasound, magnetic resonance cholangiopancreatography, and intraoperative cholangiography fit in the management of acute biliary pancreatitis? A decision analysis model
    M R Arguedas
    Department of Medicine, University of Alabama at Birmingham, 35294-0007, USA
    Am J Gastroenterol 96:2892-9. 2001
  9. ncbi Barrett's oesophagus: a review of costs of the illness
    M R Arguedas
    Department of Medicine, Center for Outcomes and Effectiveness Research and Education, University of Alabama at Birmingham, 35294-0007, USA
    Pharmacoeconomics 19:1003-11. 2001
  10. ncbi Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding
    D L Raines
    Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
    Aliment Pharmacol Ther 19:571-81. 2004

Collaborators

Detail Information

Publications25

  1. ncbi The critically ill liver patient: the variceal bleeder
    Miguel R Arguedas
    Division of Gastroenterology and Hepatology, UAB Liver Center, University of Alabama at Birmingham, UAB Liver Center, 1918 University Blvd, Birmingham, AL 35294, USA
    Semin Gastrointest Dis 14:34-8. 2003
    ....
  2. ncbi Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients
    M R Arguedas
    UAB Liver Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham, 35294 0007, USA
    Hepatology 34:28-31. 2001
    ..These findings indicate that the response to HAV vaccination in chronic liver disease is optimal when targeted to patients before the development of hepatic decompensation...
  3. ncbi Screening for hepatocellular carcinoma: why, when, how?
    Miguel R Arguedas
    Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham, MCLM 281, 1918 University Boulevard, Birmingham, AL 35294, USA
    Curr Gastroenterol Rep 5:57-62. 2003
    ..A few studies, however, have suggested that screening may be cost-effective because a minor survival benefit could result in a cost that is acceptable to decision makers...
  4. ncbi Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis
    M R Arguedas
    Department of Medicine, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, AL 35294-0007, USA
    Aliment Pharmacol Ther 15:631-8. 2001
    ..CONCLUSION: Chemoprevention with COX-2 inhibitors in 'average-risk' postpolypectomy patients is a more expensive strategy compared to colonoscopic surveillance...
  5. ncbi Congenital vascular lesions of the gastrointestinal tract: blue rubber bleb nevus and Klippel-Trenaunay syndromes
    M R Arguedas
    Department of Medicine, University of Alabama at Birmingham, 35297-0007, USA
    South Med J 94:405-10. 2001
    ..In addition, we review the available literature on the epidemiology, transmission, clinical features, associated conditions, diagnosis, and treatment of these two disorders...
  6. ncbi Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis
    A W Dupont
    Division of Gastroenterology and Hepatology, Department of Medicine, University of Texas Medical Branch, Galveston, TX 77555 0764, USA
    Aliment Pharmacol Ther 26:431-41. 2007
    ..Aspirin chemoprevention combined with colonoscopy screening is not cost-effective for the general population. However, the cost-effectiveness of aspirin in individuals with prior adenoma resection has not been evaluated...
  7. ncbi The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation
    M R Arguedas
    Department of Medicine, UAB Liver Center, University of Alabama at Birmingham, 35294-0007, USA
    Am J Gastroenterol 96:833-7. 2001
    ..Therefore, the adherence to currently available practice guidelines and the education of physicians to implement screening in this patient population is an important goal...
  8. ncbi Where do ERCP, endoscopic ultrasound, magnetic resonance cholangiopancreatography, and intraoperative cholangiography fit in the management of acute biliary pancreatitis? A decision analysis model
    M R Arguedas
    Department of Medicine, University of Alabama at Birmingham, 35294-0007, USA
    Am J Gastroenterol 96:2892-9. 2001
    ..CONCLUSIONS: Total costs and cost-effectiveness ratios of these strategies in patients with ABP are highly dependent on the probability of CBDS...
  9. ncbi Barrett's oesophagus: a review of costs of the illness
    M R Arguedas
    Department of Medicine, Center for Outcomes and Effectiveness Research and Education, University of Alabama at Birmingham, 35294-0007, USA
    Pharmacoeconomics 19:1003-11. 2001
    ..Further epidemiological and clinical studies are likely to further define the economic impact of Barrett's oesophagus as a complication of GORD...
  10. ncbi Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding
    D L Raines
    Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
    Aliment Pharmacol Ther 19:571-81. 2004
    ....
  11. ncbi Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study
    B L Hicken
    Department of Psychology, University of Alabama, Birmingham, AL, USA
    Aliment Pharmacol Ther 17:145-53. 2003
    ....
  12. ncbi Comparison of health-related quality of life preferences between physicians and cirrhotic patients: implications for cost-utility analyses in chronic liver disease
    C D Wells
    Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Dig Dis Sci 49:453-8. 2004
    ..These results suggest that studies that have used physician-assigned utilities do not accurately reflect patient preferences...
  13. ncbi Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy?
    M R Arguedas
    Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Endoscopy 36:174-8. 2004
    ..CONCLUSIONS: For patients with suspected biliary SOD type II, empirical biliary sphincterotomy performed by experienced endoscopists appears to be cost-saving in comparison with a strategy based on the results of manometry...
  14. ncbi Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis
    Miguel R Arguedas
    Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0007, USA
    Am J Gastroenterol 98:679-90. 2003
    ....
  15. ncbi Economical and clinical outcomes of alternative treatment strategies in the management of common bile duct stones in the elderly: wait and see or surgery?
    Britt B Drake
    Department of Medicine, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, USA
    Am J Gastroenterol 101:746-52. 2006
    ..CONCLUSIONS: In patients aged 60 and older, expectant management after ERC-S for CBDS is a reasonable approach, but the economic attractiveness of this strategy is highly dependent on the probability of recurrent symptoms...
  16. ncbi Cost-effectiveness of screening for hepatopulmonary syndrome in liver transplant candidates
    D Neil Roberts
    Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294 0007, USA
    Liver Transpl 13:206-14. 2007
    ..The utility of screening depends on the prevalence and severity of HPS in the target population...
  17. ncbi Hepatopulmonary syndrome
    Miguel R Arguedas
    Department of Medicine, Division of Gastroenterology/Hepatology, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA
    Clin Liver Dis 9:733-46, viii. 2005
    ..Pathophysiologic insights obtained from experimental models may lead to the development of novel and effective medical treatments...
  18. ncbi A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer
    Victor K Chen
    Division of Gastroenterology and Hepatology, Department of Medicine, School of Public Health, The University of Alabama at Birmingham, Birmingham, Alabama 35294-0007, USA
    Am J Gastroenterol 99:2223-34. 2004
    ..In addition to local expertise and availability, costs and diagnostic yield should be considered when choosing an optimal diagnostic strategy...
  19. ncbi Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection
    Miguel R Arguedas
    Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Am J Gastroenterol 99:1023-8. 2004
    ..Our study highlights the importance of using primary, patient-derived data rather than expert opinion...
  20. ncbi The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States
    Miguel R Arguedas
    Division of Gastroenterology and Hepatology, School of Public Health, University of Alabama at Birmingham, 35294-0007, USA
    Am J Gastroenterol 97:721-8. 2002
    ..Universal vaccination is not a cost-effective alternative to targeted vaccination in this target population...
  21. ncbi Hepatitis A and considerations regarding the cost-effectiveness of vaccination programs
    Matthew G Deneke
    Department of Internal Medicine University Of Alabama at Birmingham, Birmingham, AL 35294, USA
    Expert Rev Vaccines 2:661-72. 2003
    ..In this manuscript, the available data from the literature regarding the cost-effectiveness of hepatitis vaccination programs in healthy individuals and in those with chronic liver disease are reviewed...
  22. ncbi Early administration of vapreotide for variceal bleeding in patients with cirrhosis
    Mohamad A Eloubeidi
    Gastrointest Endosc 55:135-7. 2002
  23. ncbi Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices
    Miguel R Arguedas
    Department of Medicine, University of Alabama at Birmingham, USA
    Am J Gastroenterol 97:2441-52. 2002
    ..CONCLUSIONS: Screening for varices is an affordable strategy in compensated liver disease, whereas universal primary prophylaxis with beta-blockers is cost-effective in decompensated patients...
  24. ncbi Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis
    Miguel R Arguedas
    Division of Gastroenterology and Hepatology, School of Public Health, University of Alabama at Birmingham, 35294-0007, USA
    Am J Gastroenterol 97:898-904. 2002
    ..CONCLUSION: Initial endoscopic placement of a metal stent is a cost-saving strategy compared to initial plastic stent placement, particularly in patients expected to survive longer than 6 months...
  25. ncbi Assessment of the PHQ-9 as a screening tool for depression in patients with chronic hepatitis C
    Nader Dbouk
    Department of Internal Medicine, The University of Alabama at Birmingham, 1530 3rd Avenue South BDB 327, Birmingham, AL 35294, USA
    Dig Dis Sci 53:1100-6. 2008
    ..We examined the test characteristics of the PHQ-9, a new screening tool that has been validated in the general population but not amongst patients with hepatitis C virus (HCV)...